Supreme People’s Court of China [2023]: Yangtze River Pharmaceutical Group v HIPI Pharma Tech,
WIPO Lex
RetourDate du jugement25 mai 2023JuridicitonSupreme People’s Court of the People’s Republic of ChinaDegrés de juridictionInstance finaleType de procédureJudiciaire (civil)SujetConcurrence, Brevets (Inventions)Plaignant/RequérantYangtze River Pharmaceutical Group Guangzhou Hairui Pharmaceutical Co., Ltd; Yangtze River Pharmaceutical Group Co., Ltd.DéfendeurHefei Industrial Pharmaceutical Institute Co., Ltd; Hefei Enrite Pharmaceutical Co., Ltd.Mots clés
Patent,
Abuse of dominant market position,
Restricting dealing,
Unfairly high price
Jugement/DécisionAnglaisSupreme People’s Court of China [2023]: Yangtze River Pharmaceutical Group v HIPI Pharma Tech HTMLRésuméAnglaisSupreme People’s Court of China [2023]: Yangtze River Pharmaceutical Group v HIPI Pharma Tech HTMLN° WIPO LexWIPOLEX016-j